Labshake search
Citations for R&D Systems :
1 - 50 of 3579 citations for 3 Phenoxybenzoic Acid Unlabeled 100 Ug Ml In Acetonitrile since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: ... or 100 ug/mL NRP-1 Antibody (R&D Systems) every other day for 5 days.
-
bioRxiv - Microbiology 2023Quote: ... or 3 ug/ml of an anti-Dectin-1 antibody (MAB1859; R&D Systems). Mouse IgG was used as a control ...
-
bioRxiv - Cancer Biology 2022Quote: ... The following neutralizing antibodies were used: anti-CXCL12 (R&D systems, clone 79014, 100 ug/ml) and anti-CXCL2 (Thermo Fisher ...
-
bioRxiv - Neuroscience 2024Quote: ... agrin (R&D Systems; 0.1 ug/mL) was added (Sup ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with FGF2 (4 ug/mL; Biochemistry Department, University of Cambridge) and TGF-β1 (1.74 ug/mL; R&D Systems) using Vitronectin XF (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2021Quote: ... Capture antibody (R&D Systems, BAF1729, 0.25 ug/ml) was applied at RT for 1 hour ...
-
bioRxiv - Immunology 2021Quote: ... unlabeled goat α-MERTK (R&D systems), and donkey α-goat secondary (AF647 ...
-
bioRxiv - Immunology 2021Quote: ... unlabeled goat α-MERTK (R&D systems), and donkey α-goat secondary (AF647 ...
-
bioRxiv - Cell Biology 2021Quote: ... CTSD (1 ug/mL, R&D Systems cat. no. AF1014), β-actin (1:1000 ...
-
bioRxiv - Bioengineering 2022Quote: ... IgG1 antibody control (30 ug/mL, R&D Systems, MAB002), ICAM-1/CD54 (10ug/mL ...
-
bioRxiv - Neuroscience 2023Quote: ... Sigma P4957)/laminin (10 ug/mL, R&D Systems 3400-010-02) and subsequent manual rosette selection and expansion ...
-
bioRxiv - Bioengineering 2024Quote: ... 3 µm CHIR99021 (Stemgent) and 100 ng/ml SHH (R&D Systems) for 5 days ...
-
bioRxiv - Molecular Biology 2022Quote: ... iPSC at 60-70% confluence were treated for 3 days with 100 ng/mL Activin A and 100 ng/mL bFGF (R&D Systems) in the presence of increasing levels of FBS (0% on day 1 ...
-
The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residencybioRxiv - Immunology 2022Quote: ... FMS-like tyrosine kinase-3 ligand (FLT3-L) (100 ng/mL, R&D systems) and thrombopoietin (TPO ...
-
bioRxiv - Microbiology 2022Quote: ... and 2 ug/mL of MetAP enzyme (R&D Systems 3537-ZN). Product detection,each reaction well is supplemented with 25 uL of 2 ng/mL DPPIV/CD26 (serine exopeptidase diluted in activation buffer).
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Immunology 2021Quote: ... Blocking of ACE2 was performed with 8 ug/mL anti-ACE2 (R&D systems) for 30 min at 37°C before adding stimuli ...
-
bioRxiv - Genetics 2021Quote: ... 3 ng/ml mouse IL-3 (R&D Systems) and 20% L-cell conditioned medium ...
-
bioRxiv - Bioengineering 2021Quote: ... 100 ng/mL human Fms-related tyrosine kinase 3 ligand (Flt3L, #308-FK, all R&D Systems), 2 mM L-GlutaMAX (Gibco #35050-038) ...
-
bioRxiv - Bioengineering 2020Quote: ... 100 μl of stop solution (Sulfuric acid) (R&D systems) was added ...
-
bioRxiv - Neuroscience 2022Quote: ... and Neurotrophin-3 (NT-3, 20ng/ml, R&D systems) were used for neural differentiation between days 27 and 41 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 100 U/mL rmIL-2 (402-ML-100, R&D Systems) in the presence of increasing concentrations of SU11652 (sc-204310 ...
-
bioRxiv - Immunology 2021Quote: ... or 5 ug/ml isotype or neutralizing monoclonal anti-hIL-33 antibodies (R&D Systems, MAB36254), followed by stimulation with rIL-33 (Peprotech) ...
-
bioRxiv - Neuroscience 2020Quote: ... Primary antibodies used for immunoblotting were sheep anti-DRAXIN (AF6149, R&D systems, 1 ug/mL), goat anti-β-ACTIN (AB0145-200 ...
-
bioRxiv - Microbiology 2023Quote: FimHLD (40 ug/mL) was incubated with serial dilutions of HMGB1 recombinant protein (R&D systems) for 1 hour at room temperature ...
-
bioRxiv - Bioengineering 2023Quote: ... B cell activating medium was supplemented with 5 ug/mL anti-CD40 antibody (R&D systems) and 20 ng/mL IL-4 (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... PBMCs were cultured for 8 days and stimulated with 2.5 ng/mL crude peanut extract (Stallergenes Greer) with or without 50 ug/mL anti-human IL-4Ra (R&D Systems), as previously described (17).
-
bioRxiv - Cancer Biology 2022Quote: ... human interleukin-3 (IL-3, 10 ng/mL, R&D Systems), human interleukin-6 (IL-6 ...
-
bioRxiv - Bioengineering 2019Quote: Stage 1: 3 days in S1 basal media with 100 ng/ml Activin A (R&D Systems; 338-AC) and 3 μM CHIR99021 (Stemgent ...
-
bioRxiv - Developmental Biology 2023Quote: ... VEGFR-3 (AF349, R&D Systems, 1:100, RRID:AB_355314), Coup-TF2 (EPR18443 ...
-
bioRxiv - Cell Biology 2020Quote: ... 3 ng/mL mFGF2 (R&D Systems), 1xITS (Millipore Sigma)) ...
-
bioRxiv - Genetics 2023Quote: ... 10ng/ml IL-3 (R&D systems) and Ls513 cells were cultured in RPMI 1640 medium supplemented with 10% FBS ...
-
bioRxiv - Immunology 2024Quote: ... 3 ng/mL GMCSF (R&D systems) and 200 ng/mL Flt3-L (R&D systems ...
-
bioRxiv - Cell Biology 2019Quote: ... 2 ug/ml Doxycycline and 3.34 ug/ml Puromycin, 1 × N27 supplement, and 10 ng/ml BDNF (STEMCELL, 78005) and GDNF (R&D Systems, 212-GD)) ...
-
bioRxiv - Immunology 2024Quote: ... treated with 100 ng/mL IL-1β (R&D Systems, #401-ML-005, 100 µg/mL stock in PBS) and 50 ng/mL TNF (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... 100 ng/ml Noggin(R&D Systems # 6057-NG-100), 500 nM A83-01 (Tocris # 2939) ...
-
bioRxiv - Cancer Biology 2020Quote: ... recombinant mouse IL-3 (10ug/ml) (R&D systems #403-ML), 50uL recombinant mouse SCF (10ug/ml ...
-
bioRxiv - Molecular Biology 2024Quote: ... and 10ng/mL IL-3 (R&D systems #403-ML-010).
-
bioRxiv - Cancer Biology 2023Quote: ... 40ng/mL recombinant human FGF (R&D systems, 100-18B-100), 0.5 × B27 serum free supplement (ThermoFisher Scientific ...
-
bioRxiv - Immunology 2024Quote: ... Mice were injected with 100 ng/mL IL-1β (R&D Systems, #401-ML-005, 100 µg/mL stock in PBS) and 50 ng/mL TNF (R&D Systems ...
-
bioRxiv - Genomics 2021Quote: ... or 3 ng/ml TGFB (R&D Systems), or both ...
-
bioRxiv - Immunology 2020Quote: ... TGF-β (3 ng/ml, R&D Systems) and Retinoic Acid (RA ...
-
bioRxiv - Physiology 2022Quote: ... rhuIL-3 (1 ng/ml, R&D Systems). Erythropoiesis was induced by addition of 3 U/ml recombinant human erythropoietin (rEPO ...
-
bioRxiv - Neuroscience 2023Quote: ... 10 ng/ml Interleukin-3 (R&D Systems), 10 ng/ml Interleukin-6 (R&D Systems) ...
-
bioRxiv - Genomics 2023Quote: ... and NT-3 (20ng/ml, R&D Systems) every two days ...
-
bioRxiv - Microbiology 2020Quote: ... hESCs were cultured to achieve 80-90% confluency, and treated with 3 μM CHIR99021 (CHIR, Stem-RD) and 100 ng/ml Activin A (R&D systems) in basal medium RPMI1640 (Cellgro ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were seeded at 1.5×105/ml in primary differentiation medium supplemented with 1ng/ml interleukin-3 (IL-3, R&D Systems), 10ng/ml SCF and 1μg/ml doxycycline ...
-
bioRxiv - Immunology 2024Quote: ... Primary astrocytes were treated with 100 ng/mL IL-1β (R&D Systems, #401-ML-005, 100 µg/mL stock in PBS) and 50 ng/mL TNF (R&D Systems ...
-
bioRxiv - Neuroscience 2022Quote: ... DIV12 hippocampal neurons were treated with either 2 ug/mL of recombinant Nptx2 (CF 7816-NP-050, R&D Systems) or BSA as control ...
-
bioRxiv - Developmental Biology 2021Quote: ... 100 ng/ml GDF7 (R&D Systems). Depending on culture conditions used ...